Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
Clinical trial NCT01065129 · COMPLETED
Trial details
- NCT number
- NCT01065129
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-02
- Primary completion
- 2014-07-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.